SO
BBIO icon

STRS Ohio’s BridgeBio Pharma BBIO Stock Holding History

STRS Ohio’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Sell
3,564
-20,136
-85% -$1.41M ﹤0.01% 1463
2026
Q1 		$1.76M Buy
23,700
+2,500
+12% +$181K 0.01% 595
2025
Q4 		$1.62M Buy
21,200
+2,600
+14% +$171K 0.01% 604
2025
Q3 		$966K Buy
18,600
+200
+1% +$9.76K ﹤0.01% 704
2025
Q2 		$795K Buy
18,400
+6,600
+56% +$240K ﹤0.01% 1008
2025
Q1 		$408K Buy
11,800
+4,400
+59% +$148K ﹤0.01% 1287
2024
Q4 		$203K Buy
7,400
+500
+7% +$12.9K ﹤0.01% 1504
2024
Q3 		$176K Hold
6,900
– – ﹤0.01% 1592
2024
Q2 		$175K Buy
6,900
+2,200
+47% +$60.1K ﹤0.01% 1594
2024
Q1 		$145K Sell
4,700
-4,300
-48% -$146K ﹤0.01% 1625
2023
Q4 		$363K Buy
9,000
+2,100
+30% +$63.1K ﹤0.01% 1406
2023
Q3 		$181K Buy
+6,900
New +$196K ﹤0.01% 1588
2022
Q1 		– Sell
-7,300
Closed -$121K – 2145
2021
Q4 		$121K Sell
7,300
-3,600
-33% -$152K ﹤0.01% 1860
2021
Q3 		$510K Sell
10,900
-2,600
-19% -$139K ﹤0.01% 1500
2021
Q2 		$822K Sell
13,500
-800
-6% -$45.7K ﹤0.01% 1305
2021
Q1 		$880K Buy
14,300
+6,400
+81% +$419K ﹤0.01% 1244
2020
Q4 		$561K Buy
7,900
+2,600
+49% +$125K ﹤0.01% 1413
2020
Q3 		$198K Buy
5,300
+500
+10% +$15.7K ﹤0.01% 1672
2020
Q2 		$156K Buy
+4,800
New +$146K ﹤0.01% 1693
2020
Q1 		– Sell
-5,900
Closed -$206K – 2026
2019
Q4 		$206K Hold
5,900
– – ﹤0.01% 1668
2019
Q3 		$126K Buy
+5,900
New +$163K ﹤0.01% 1729

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

STRS Ohio's BBIO Position: Q2 2026 in Review

STRS Ohio reduced its BridgeBio Pharma (BBIO) stake by 85% in Q2 2026, selling an estimated $1.41M and leaving 3,564 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

STRS Ohio first reported a position in BBIO in Q3 2019 and has held it in 21 quarters since. The position peaked at $1.76M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • STRS Ohio held 3,564 shares of BridgeBio Pharma worth $265K as of Q2 2026.
  • STRS Ohio sold 20,136 BridgeBio Pharma shares in Q2 2026, an estimated $1.41M.
  • BridgeBio Pharma made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1463 holding.
  • STRS Ohio first reported a position in BridgeBio Pharma in Q3 2019 and has held it in 21 quarters since.
  • STRS Ohio's BridgeBio Pharma position peaked at $1.76M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.